BOK Financial’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$673K Sell
4,488
-893
-17% -$97.1K 0.01% 504
2026
Q1
$497K Sell
5,381
-890
-14% -$89.4K 0.01% 538
2025
Q4
$641K Sell
6,271
-3,958
-39% -$354K 0.01% 488
2025
Q3
$639K Sell
10,229
-6,690
-40% -$364K 0.01% 516
2025
Q2
$880K Sell
16,919
-685
-4% -$30.6K 0.01% 463
2025
Q1
$750K Buy
+17,604
New +$759K 0.01% 477
2023
Q3
Sell
-113
Closed -$4.04K 1216
2023
Q2
$4.04K Buy
+113
New +$3.25K ﹤0.01% 985

Other funds holding GH

BOK Financial's GH Position: Q2 2026 in Review

BOK Financial reduced its Guardant Health (GH) stake by 17% in Q2 2026, selling an estimated $97.1K and leaving 4,488 shares worth $673K. The position accounts for 0.01% of the portfolio, ranked #504.

BOK Financial first reported a position in GH in Q2 2023 and has held it in 7 quarters since. The position peaked at $880K in Q2 2025. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • BOK Financial held 4,488 shares of Guardant Health worth $673K as of Q2 2026.
  • BOK Financial sold 893 Guardant Health shares in Q2 2026, an estimated $97.1K.
  • Guardant Health made up 0.01% of BOK Financial's portfolio in Q2 2026, its #504 holding.
  • BOK Financial first reported a position in Guardant Health in Q2 2023 and has held it in 7 quarters since.
  • BOK Financial's Guardant Health position peaked at $880K in Q2 2025.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on BOK Financial's 13F filing for Q2 2026, filed 10 Aug 2026.